The Drug Policy Alliance issued a report saying patients and caregivers in New York State face significant obstacles to obtain medical marijuana because of geographic barriers, high product costs, and a dearth of physicians certified to recommend MMJ.
The findings raise questions about the viability of New York’s medical cannabis industry as it’s currently structured, and whether MMJ prices will need to fall. The program was launched in January.
DPA and Compassionate Care NY, the state’s largest grassroots organization of patients and caregivers, surveyed 255 people who had sought to access the state’s MMJ program.
More than three-quarters of
DPA Report: NY Medical Cannabis Program Hard to Access is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs
Continue to source
DPA Report: NY Medical Cannabis Program Hard to Access
A leading source of financial, legal and other business news for the cannabis industry